PMC:7402624 / 40382-40597
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T371 | 92-94 | Body_part | denotes | PB | http://purl.org/sig/ont/fma/fma84371 |
| T372 | 170-172 | Body_part | denotes | PB | http://purl.org/sig/ont/fma/fma84371 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1435 | 67-75 | Species | denotes | patients | Tax:9606 |
| 1436 | 145-153 | Species | denotes | patients | Tax:9606 |
| 1445 | 92-94 | Chemical | denotes | PB | |
| 1446 | 170-172 | Chemical | denotes | PB | |
| 1454 | 109-123 | Disease | denotes | hyperlipidemia | MESH:D006949 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T311 | 92-94 | Disease | denotes | PB | http://purl.obolibrary.org/obo/MONDO_0019035 |
| T312 | 109-123 | Disease | denotes | hyperlipidemia | http://purl.obolibrary.org/obo/MONDO_0021187 |
| T313 | 170-172 | Disease | denotes | PB | http://purl.obolibrary.org/obo/MONDO_0019035 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T278 | 92-94 | Chemical | denotes | PB | http://purl.obolibrary.org/obo/CHEBI_53319|http://purl.obolibrary.org/obo/CHEBI_60686 |
| T280 | 170-172 | Chemical | denotes | PB | http://purl.obolibrary.org/obo/CHEBI_53319|http://purl.obolibrary.org/obo/CHEBI_60686 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T12 | 109-123 | Phenotype | denotes | hyperlipidemia | http://purl.obolibrary.org/obo/HP_0003077 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T234 | 0-215 | Sentence | denotes | Examining categorical rather than continuous clinical data, 80% of patients with decreasing PB over time had hyperlipidemia, whereas only 20% of patients with increasing PB over time had this comorbidity (fig. S6D). |